Aspartic Acid

Aspartic Acid

SCHEMBL8383423

CC.N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.56
GRIK1 P39086 10/20 0.54
GRIK2 Q13002 6/20 0.54
SLC1A1 P43005 5/20 0.52
GRM1 Q13255 2/20 0.52
GRM2 Q14416 2/20 0.52
SLC1A3 P43003 5/20 0.50
SLC1A2 P43004 5/20 0.50
GRIA4 P48058 4/20 0.50
GRIK3 Q13003 4/20 0.50
GRIK5 Q16478 4/20 0.50
GRIA2 P42262 3/20 0.50
GRIA1 P42261 2/20 0.50
GRM8 O00222 1/20 0.50
GRM6 O15303 1/20 0.50
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
GSR P00390 1/20 0.50
CYP1A2 P05177 1/20 0.50
GRM5 P41594 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL7204819 0.94 SLC7A5 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1
Aspartic Acid SCHEMBL28054217 0.94 SLC7A5 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1
Aspartic Acid SCHEMBL7204816 0.94 SLC7A5 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1
Aspartic Acid SCHEMBL3231 0.94
Aspartic Acid SCHEMBL1526976 0.94 GRIK1 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1
Aspartic Acid SCHEMBL11065189 0.94 GRIK1 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1
D-Aspartate SCHEMBL145539 0.94
Aspartic Acid SCHEMBL3230 0.94
Aspartic Acid SCHEMBL996424 0.94 GRIK1 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1
Aspartic Acid SCHEMBL11065185 0.94 GRIK1 (0.56) SLC7A5GRIK1GRIK2SLC1A1GRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed